Acadian Asset Management LLC Ovid Therapeutics Inc. Transaction History

Acadian Asset Management LLC

$28.7 Billion
Q1 2024

A detailed history of Acadian Asset Management LLC transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,655,871 shares of OVID stock, worth $1.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,655,871

Previous 1,655,871 -0.0%

Holding current value

$1.28 Million

Previous $5.33 Million 5.27%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.98 - $3.78 $135,163 - $171,449	-45,357 Reduced 2.67%	1,655,871 $5.33 Million
Q3 2023 Nov 13, 2023	SELL	$3.23 - $3.97 $256,791 - $315,622	-79,502 Reduced 4.46%	1,701,228 $6.53 Million
Q2 2023 Aug 07, 2023	SELL	$2.53 - $3.89 $361 - $556	-143 Reduced 0.01%	1,780,730 $5.84 Million
Q1 2023 May 11, 2023	SELL	$1.88 - $2.85 $63,335 - $96,013	-33,689 Reduced 1.86%	1,780,873 $4.59 Million
Q4 2022 Feb 14, 2023	SELL	$1.43 - $1.86 $21,149 - $27,509	-14,790 Reduced 0.81%	1,814,562 $3.37 Million

Q3 2022 Nov 14, 2022	SELL	$1.85 - $2.26 $225,905 - $275,970	-122,111 Reduced 6.26%	1,829,352 $3.36 Million
Q2 2022 Aug 09, 2022	SELL	$1.69 - $3.31 $317,427 - $621,707	-187,827 Reduced 8.78%	1,951,463 $4.2 Million
Q1 2022 May 12, 2022	BUY	$2.65 - $3.49 $262,895 - $346,228	99,206 Added 4.86%	2,139,290 $6.72 Million
Q4 2021 Feb 10, 2022	BUY	$3.13 - $3.73 $428,565 - $510,719	136,922 Added 7.19%	2,040,084 $6.54 Million
Q3 2021 Nov 12, 2021	BUY	$3.31 - $4.04 $214,871 - $262,260	64,916 Added 3.53%	1,903,162 $6.39 Million
Q2 2021 Aug 11, 2021	BUY	$3.3 - $4.49 $2.89 Million - $3.93 Million	875,770 Added 90.99%	1,838,246 $7.19 Million
Q1 2021 May 11, 2021	BUY	$2.42 - $4.47 $1.48 Million - $2.73 Million	609,818 Added 172.92%	962,476 $3.87 Million
Q4 2020 Feb 11, 2021	BUY	$2.28 - $6.84 $804,060 - $2.41 Million	352,658 New	352,658 $815,000
Q3 2020 Nov 09, 2020	SELL	$5.39 - $8.24 $22,443 - $34,311	-4,164 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$2.67 - $7.91 $244,502 - $724,350	-91,574 Reduced 95.65%	4,164 $31,000
Q1 2020 May 11, 2020	SELL	$2.03 - $4.35 $269,222 - $576,905	-132,622 Reduced 58.08%	95,738 $285,000
Q4 2019 Feb 06, 2020	SELL	$2.08 - $5.06 $9,106 - $22,152	-4,378 Reduced 1.88%	228,360 $947,000
Q3 2019 Nov 07, 2019	BUY	$1.76 - $3.51 $37,396 - $74,580	21,248 Added 10.05%	232,738 $755,000
Q2 2019 Aug 08, 2019	BUY	$1.59 - $2.14 $91,571 - $123,246	57,592 Added 37.42%	211,490 $392,000
Q1 2019 May 09, 2019	BUY	$1.77 - $3.56 $222,471 - $447,456	125,690 Added 445.58%	153,898 $272,000
Q3 2018 Oct 30, 2018	BUY	$5.6 - $11.0 $47,482 - $93,269	8,479 Added 42.98%	28,208 $160,000
Q2 2018 Jul 24, 2018	BUY	$6.16 - $10.14 $75,731 - $124,661	12,294 Added 165.35%	19,729 $154,000
Q1 2018 Apr 12, 2018	BUY	$6.53 - $9.82 $48,550 - $73,011	7,435 New	7,435 $52,000

Others Institutions Holding OVID

# of Institutions

Shares Held

43.2M

Call Options Held

5.9K

Put Options Held

300

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $54.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Ovid Therapeutics Inc. Transaction History